You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
CR I 2O13 <strong>Program</strong> at-a-Glance<br />
DAY HALL B2 TIME/TYPE B402 B406 B308 B313 Ballroom 3-4 Ballroom 1-2 Hall B1 TIME/TYPE DAY<br />
SUNDAY 3/3/13<br />
MONDAY 3/4/13<br />
TUESDAY 3/5/13<br />
WEDNESDAY 3/6/13<br />
Poster<br />
Set-up<br />
7 am-7 pm<br />
Posters<br />
Open<br />
7 am-7 pm<br />
Posters<br />
Open<br />
7 am-7 pm<br />
Posters<br />
Open<br />
7 am-6 pm<br />
Poster<br />
Removal<br />
6-9 pm<br />
9 am-1:30 pm<br />
Workshop<br />
2:30-4:30 pm<br />
Workshop<br />
5-7 pm<br />
Opening<br />
1. New Investigators and<br />
Trainees Workshop<br />
9 am-1:30 pm<br />
Workshop<br />
2. Frontiers in Lab Sci 3. Clinical Trials Design 2:30-4:30 pm<br />
Workshop<br />
4. 18 th Bernard Fields<br />
Lecture and 7 th<br />
N’Galy-Mann Lecture<br />
7-10 pm 7-10 pm<br />
Welcome Reception<br />
8:30-9 am<br />
Plenary<br />
9-9:30 am<br />
Plenary<br />
10 am-12 n<br />
Oral Abstracts<br />
1:30-2:30 pm<br />
Themed<br />
Discussion<br />
2:30-4 pm<br />
Poster Abstracts<br />
4-6 pm<br />
Symposia + Oral<br />
Abstracts<br />
8:30-9 am<br />
Plenary<br />
9-9:30 am<br />
Plenary<br />
10 am-12 n<br />
Oral Abstracts<br />
1:30-2:30 pm<br />
Themed<br />
Discussion<br />
2:30-4 pm<br />
Poster Abstracts<br />
4-6 pm<br />
Symposia<br />
8:30-9 am<br />
Plenary<br />
9-9:30 am<br />
Plenary<br />
10 am-12 n<br />
Oral Abstracts<br />
1:30-2:30 pm<br />
Themed<br />
Discussion<br />
2:30-4 pm<br />
Poster Abstracts<br />
4-6 pm<br />
Symposium<br />
11. Simian Viral<br />
Reservoirs<br />
27. Mining Sequence<br />
Data to Understand<br />
Transmission and<br />
Disease<br />
10-11:45 am<br />
39. New Discoveries in<br />
Vaccines and Gene<br />
Therapy<br />
44. Aging and<br />
Neurocognitive<br />
Function in HIV<br />
Infection<br />
10-11:30 am<br />
7. Neurocognitive<br />
Disorders: New<br />
Developments and<br />
Therapies<br />
12. Tenofovir in Children 13. New Approaches to<br />
ARV Drug Delivery<br />
17. Is Something<br />
Bugging You?<br />
23. HIV/SIV–Host<br />
Interaction<br />
28. Restriction Factors:<br />
Old and New<br />
33. HIV–Host Cell<br />
Interactions<br />
40. Virology: From the<br />
Outside In<br />
45. Transmitted/<br />
Founder Viruses<br />
50. Progress in<br />
Deciphering HIV<br />
Protective Immunity<br />
29. MSM in the<br />
Developing World<br />
46. Emergence and<br />
Persistence of<br />
HPV-associated<br />
Malignancies in<br />
the ART Era<br />
14. Implementation and<br />
Cost-effectiveness<br />
of Male Circumcision<br />
30. Family Planning:<br />
Unintended<br />
Pregnancy and<br />
Unmet Need<br />
47. Mechanisms<br />
of Immune<br />
Reconstitution<br />
10 am-12:15 pm<br />
8. HIV Prevention:<br />
ARV, Counselling,<br />
Contraception, and<br />
Condoms<br />
15. What Is Latency and<br />
What Can We Do<br />
about It?<br />
10 am-12:15 pm<br />
9. Advances in Hepatitis<br />
Therapy<br />
16. Statin Use and HIV:<br />
How Sweet Is It?<br />
18. Preventing HIV/AIDS Oral Abstracts Session<br />
in the US: Can We Do 19. Cardiovascular<br />
Better?<br />
Disease and Other<br />
Non-AIDS Events:<br />
Epidemiology and<br />
Pathogenesis<br />
10 am-12:15 pm<br />
24. MTCT and HIV<br />
Treatment in Children<br />
31. The Cascade<br />
of Care<br />
34. Reproductive<br />
Hormones and HIV<br />
25. North and South:<br />
Epidemiology and<br />
Engagement in Care<br />
32. Cardiovascular<br />
Disease: Predicting<br />
Risk and Monitoring<br />
Outcomes<br />
35. When Worlds<br />
Collide–Adolescents<br />
and HIV<br />
10-11 am<br />
10 am-12:15 pm<br />
41. HIV-associated 43. Advances in ARV<br />
Malignancies<br />
and Anti-Hepatitis C<br />
11 am-12:15 pm<br />
42. TB and Cryptococcal<br />
Meningitis<br />
Virus Therapy<br />
48. Adherence and<br />
Retention in RLS<br />
51. HIV Testing and<br />
Monitoring the<br />
Epidemic: New Tools<br />
for Patients and<br />
Populations<br />
49. Inflammatory<br />
Biomarkers,<br />
Microparticles,<br />
and Clinical<br />
Outcomes in HIV<br />
5. HIV-1 Eradication<br />
Strategies: Design,<br />
Assessment, and<br />
Clinical Consequences<br />
6. Reality Check: Is the<br />
End of AIDS in Sight?<br />
10 am-12:15 pm<br />
10. Is There Hope for<br />
HIV Eradication?<br />
20. New Frontiers in<br />
Hepatitis C Virus<br />
Treatment<br />
21. The Global MSM<br />
HIV Epidemic:<br />
Time to Act<br />
22. Evolution of the<br />
Host–Virus<br />
Interaction: A Guide<br />
to the Development<br />
of Novel<br />
Therapeutics?<br />
10 am-12:15 pm<br />
26. ART: New Agents<br />
and New Insights<br />
36. Opportunities<br />
and Threats to<br />
ART Success<br />
37. Incorporating New<br />
Drugs into Regimens<br />
that Will Change the<br />
TB Treatment<br />
Paradigm: The<br />
Magic Mountain<br />
Meets Table<br />
Mountain<br />
38. Treatment with<br />
Gene-modified<br />
Hematopoietic Stem<br />
Cells May<br />
Definitively Abolish<br />
HIV-1 Infection<br />
5-7 pm<br />
Opening<br />
8:30-9 am<br />
Plenary<br />
9-9:30 am<br />
Plenary<br />
10 am-12 n<br />
Oral Abstracts<br />
1:30-2:30 pm<br />
Themed<br />
Discussion<br />
2:30-4 pm<br />
Poster Abstracts<br />
4-6 pm<br />
Symposia + Oral<br />
Abstracts<br />
8:30-9 am<br />
Plenary<br />
9-9:30 am<br />
Plenary<br />
10 am-12 n<br />
Oral Abstracts<br />
1:30-2:30 pm<br />
Themed<br />
Discussion<br />
2:30-4 pm<br />
Poster Abstracts<br />
4-6 pm<br />
Symposia<br />
8:30-9 am<br />
Plenary<br />
9-9:30 am<br />
Plenary<br />
10 am-12 n<br />
Oral Abstracts<br />
1:30-2:30 pm<br />
Themed<br />
Discussion<br />
2:30-4 pm<br />
Poster Abstracts<br />
52. TB on the Verge 4-6 pm<br />
Symposium<br />
SUNDAY 3/3/13<br />
MONDAY 3/4/13<br />
TUESDAY 3/5/13<br />
WEDNESDAY 3/6/13
Change language